We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit a Manuscript to the Journal

Renal Failure

For an Article Collection on

Nutraceuticals in Kidney Healthy Aging and Kidney Disease

Abstract deadline
01 August 2023

Manuscript deadline
01 August 2023

Cover image - Renal Failure

Article collection guest advisor(s)

Dr Giacomo Garibotto , Department of Internal Medicine, Università degli studi di Genova, Italy

Submit an ArticleVisit JournalArticles

Nutraceuticals in Kidney Healthy Aging and Kidney Disease

Kidney diseases, including both acute kidney injury (AKI) and chronic kidney disease (CKD), are a major public health concern. CKD affects ~10% of the general adult population. Epidemiological data show a continuous growth in its incidence and prevalence, a finding which underscores the ineffectiveness of current strategies on its prevention and treatment. The new epidemics of obesity and diabetes, through their negative effects on the kidney as well as associated morbidity, are focal points of the world increase in CKD. In turn, CKD drastically increases the risk for cardiovascular morbidity and mortality.

Effectively treating CKD would imply slowing disease progression, preventing the development of end-stage kidney disease (ESKD) and cardiovascular complications, thereby increasing survival. During the last few years it has become evident that healthy lifestyle behaviours, such as regular aerobic exercise and certain dietary patterns, are necessary as "first-line" strategies to help the kidney to maintain a “healthy” state and to prevent CV dysfunction. In particular, targeting fundamental mechanisms of renal and CV aging with nutraceuticals seems to represent a promising approach.

Nutraceuticals are showing effectiveness in small clinical trials and their potential clinical role is expanding. Data from the last 5-10 years provides evidence for their possible use in accelerated kidney aging (“kidney cell senescence”), obesity, metabolic syndrome, type 2 diabetes mellitus, dyslipidaemia, and osteoporosis. High-quality research in this area might sustain implementation of nutraceuticals into general health practice.

This Article Collection aims to collect and disseminate the most relevant research concerning the protective effects of nutraceuticals on kidney health, also in view of the current scenarios induced by an aging population and the obesity and diabetes epidemics.

Article Collection Content: Case studies, Original Reports, Reviews

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.